We conclude that stimulation of calcium uptake by distal convoluted tubule cells requires activation of both PKA and PKC. (Endocrinology 137: 13-20, 1996) I?
TH IS THE PRIMARY hormone regulating the concentration of extracellular calcium in mammals (for review, see Ref. 1) . Upon decreases in extracellular calcium activity, PTH is released and acts on target tissues to stimulate osseous calcium mobilization and reduce renal calcium excretion. PTH also activates 25-hydroxyvitamin D,-1~hy-droxylase, which increases the formation of 1,25-dihydroxyvitamin D, and, in turn, stimulates intestinal calcium absorption (2). In the kidneys, reductions of calcium excretion are due to stimulation of calcium absorption by PTH in distal convoluted tubules and, in the rabbit, connecting tubules (3).
The cellular mechanism by which binding of PTH to its cognate receptor is transduced to the subsequent stimulation of calcium absorption is not known. Conflicting evidence has been presented regarding the second messengers participating in PTH action. It has generally been thought that the effects of PTH were mediated through the adenylyl cyclase-CAMP-protein kinase A (PKA) pathway, because the addition of exogenous CAMP analogues or forskolin could largely reproduce the effects of PTH (3,4). The complementary DNA for PTH/PTH-related protein (PTHrP) receptor (5) and, more recently, the gene (6, 7) have been cloned and expressed. The results provide conclusive evidence that the receptor is capable of activating both adenylyl cyclase and phospholipase C (5, 8, 9). It is not yet known whether activation of both pathways is required for the stimulatory action of PTH on calcium transport.
In the present work, a three-pronged approach was used to define the roles of PKA and protein kinase C (PKC) as effecters of PTH action on calcium absorption.
The first step involved identifying the second messengers formed and protein kinases activated in response to challenge with PTH. and PTH was added to each remaining well, and the plate was incubated at 37 C on a covered shaking water bath for 15 min. CAMP accumulation was terminated by the addition of 0.1 ml 12% ice-cold trichloroacetic acid, and the plates were placed on ice for 1 h. Samples were put into plastic tubes, the wells were rinsed once with 0.5 ml 2% trichloroacetic acid, and the rinse was added to the plastic tubes, which were frozen at -20 C. For assay, samples were thawed and centrifuged at 2370 X g at 4 C for 25 min, and 0.9 ml supernatant was removed and transferred to a glass tube. A second rinse used a buffer containing 50 mM LiCl, which isoosmotically replaced NaCl. Cells were treated in the wells with a total of 500 ~1 buffer with or without for 2 min at 37 C on a shaking incubator. The treatment was terminated by the addition of 100 ~1 ice-cold 20% perchloric acid. Wells were scraped, and the contents were placed in a 1. Fig. 2A) . The magnitude of the response in distal convoluted tubule and cortical thick ascending limb cells was comparable to that in proximal convoluted tubule cells. In distal tubule cells, PTH had no detectable effect on InsP, formation (control, 1.27 2 0.28 pmol/tube * 2 min (n = 10); PTH, 1.27 2 0.14 pmol/ tube * 2 min (n = 4)], whereas in proximal cells, PTH elicited dose-dependent elevations in IP, formation (Fig. 2B) . " P < 0.01 US. control. n = 4 (proximal) and n = 3 (distal).
Effect of exogenous second messengers on calcium uptake
To identify the second messengers that mediate the stimulatory action of PTH on calcium transport in distal convoluted tubule cells, the effects of exogenous second messengers on calcium uptake were examined.
Because in distal convoluted tubule cells, PTH increased CAMP, but not II',, formation (Fig. 2B) (18) (19) (20) , the effects of PMA, an activator of PKC, alone and in combination with forskolin were examined. Figure 3 shows that when added at 10 nM, PMA had no effect on calcium uptake by distal convoluted tubule cells. When PMA was combined with forskolin, calcium uptake by distal convoluted tubule cells was stimulated to nearly the same extent as with a maximally effective dose of PTH (Fig. 3) . Higher concentrations of PMA in combination with forskolin caused no further stimulation of calcium uptake ( phorbol analog, 4aPMA, when added at 100 nM (i.e. a concentration 10 times greater than that of the active phorbol, PMA) had no effect on calcium uptake (2.6 + 0.1, 2.7 5 0.1 nmol/min * mg protein, respectively) when added alone or in combination with 30 nM forskolin. These results suggested that activation of both PKA and PKC is required to elicit calcium entry in distal convoluted tubule cells. transport, the effect of a higher concentration of forskolin was also assessed. At 1 PM, forskolin increased calcium entry by 30%. However, in paired observations, this concentration of forskolin stimulated CAMP accumulation in distal convoluted tubule cells by 2000%, whereas PTH at maximally effective doses induced a 500% increase in CAMP formation. The inactive forskolin analog, 1,9-dideoxyforskolin, at either 30 nM or 1 PM had no effect on calcium uptake (data not shown).
Effects of PKA and PKC inhibitors on calcium uptake
The previous experiments (Fig. 3) suggested that activation of both PKA and PKC was necessary to stimulate calcium uptake. This tentative conclusion was evaluated further in separate studies using relatively selective chemical (Rp-CAMPS and calphostin C) or sequence-specific peptide inhibitors (PKI and PKC pseudosubstrate) of PKA and PKC, respectively. Figure 4 shows that addition of either Rp-CAMPS or calphostin C blocked calcium uptake that had been stimulated by PTH or the combination of PMA plus forskolin. When added in the absence of PTH or PMA plus forskolin, neither inhibitor exerted a significant effect.
Although (Fig. 6) . Furthermore, low concentrations of forskolin, which caused stimulation of CAMP formation comparable to that produced by PTH, had no effect on calcium uptake or PKC activity (Table 3 ). In contrast, relatively high concentrations of forskolin that caused a 20-fold stimulation of CAMP formation and stimulated calcium uptake also significantly increased PKC activity (Table 3 ). This action was specific, as 1,9-dideoxyforskolin had no effect on PKC activity. Taken together, these results provide direct evidence that PTH increases PKC activity. They also suggest that at relatively high concentrations, forskolin may activate PKC. action on calcium uptake. However, simultaneous addition of 10 nM PMA, which had minimal stimulatory effects (5%) of its own on calcium transport, increased calcium uptake, albeit to a somewhat lesser extent than did PTH (Fig. 3) In the present study the effects of PTH on PKC activity were analyzed. These results verify that PTH activated PKC activity under the imposed experimental conditions. Concentrations of forskolin that caused stimulation of adenylyl cyclase comparable to that elicited by PTH failed to evoke calcium uptake. However, relatively high concentrations of forskolin alone induced calcium uptake. These results might suggest that activation of adenylyl cyclase was adequate to elicit calcium uptake, and they would be consistent with a large body of evidence that activation of the CAMP pathway alone is sufficient for stimulation of calcium transport in renal distal tubules (3,4). However, the inhibitor studies establish the requirement for PKC activation.
To resolve this apparent contradiction, the effects of forskolin on PKC activity were analyzed. The data in Table 3 show that high concentrations of forskolin are capable of activating PKC and demonstrate that the action is specific, because it is not seen with an inactive forskolin analog. To the best of our knowledge, such an action of forskolin on PKC activity has not previously been reported. At the present time, the mechanism by which this stimulatory effect of forskolin on PKC occurs is not clear. Such an action might proceed directly when intracellular CAMP is raised to particularly high levels. Alternatively, stimulation might be indirect and involve a number of phospholipases, intermediate substrates, and protein kinases. However, comparable cross-activation of cGMP-dependent protein kinase or multifunctional Ca*+/ calmodulin-dependent protein kinases by high levels of CAMP has been described (39-42). The effect of forskolin on PKC and calcium uptake shown here presumably accounts for the stimulatory action of forskolin or CAMP analogs on calcium transport by renal tubules.
PTH elicited neither InsP, formation nor a transient rise in [Ca*+], in distal convoluted tubule cells, but PTH action was clearly dependent on PKC. This raises the conspicuous question of how PKC is activated if there is no apparent stimulation of phosphoinositide-specific phospholipase C. In the absence of a convincing answer to this question, the following speculation is offered. In distal convoluted tubule cells, it is possible that occupancy of the PTH/PTHrP receptor for reasons not presently understood results in activation of adenylyl cyclase and phospholipase D. The latter enzyme hydrolyzes phosphatidylcholine, with the attendant formation of phosphatidic acid. Although phosphatidic acid may exert some physiological actions of its own (431, in the present context it is more likely that it is converted by phosphatidic acid phosphohydrolase to diacylglycerol, which activates PKC. Such a scheme would account for the dependence of PTH action on PKC without entailing In&', formation or the release of intracellular calcium with the characteristic spiking increase in [Caztli. Alternatively, in distal convoluted tubule cells, PTH/PTHrP receptor occupancy might be coupled to activation of phosphatidylcholine-specific PLC. Such a scenario is attractive because it would account for the sustained activation of PKC and the prolonged effect on calcium transport (44). Finally, an entirely distinct signaling pathway involving sphingolipid hydrolysis could be involved in mediating the action of PTH (45, 46) . For the present, it is unclear what structural differences, if any, in the PTH receptor or availability of G proteins are necessary to achieve the different signaling behaviors on distal convoluted tubule cells. 
